Skip to content
Beaune considers it normal “that we pay for innovation” – RT in French

The Secretary of State for European Affairs confirmed the information according to which Pfizer and Moderna would increase the price of their vaccines in the European Union, specifying that he was not shocked “that we are paying for innovation”.

Present on August 2 on the Cnews plateau, the Secretary of State for European Affairs, Clément Beaune, reacted to the information from the Financial Times published on August 1 according to which the company Pfizer was going to increase the price of its vaccine against Covid-19 as part of an agreement with the European Union (EU).

“Pfizer, a large American laboratory, he made it [le vaccin] thanks to a start-up, German, European, called BioNTech. They won a lot of money, that’s clear, we can discuss whether it is the right level etc. […] But they made an enormous innovation, they took an enormous risk, and that one pays the innovation so that it still arrives in the future, that does not shock me ”, he argued.

“After there is the right level of taxation, of taxation, that is a debate and I am in favor of having high taxes when there are high profits,” he said. added.

Clément Beaune confirms the information from Financial Times

A few minutes earlier on the RFI antenna, the member of the government had confirmed the information from the British daily that the Pfizer and Moderna laboratories were going to increase the price of their vaccine against Covid-19, explaining: “We must look at everything this in a rational way, obviously not to be fooled but to have more demanding contracts, with products adapted to the variants probably yes, not only for the European Union, for all the buyers it will be a little more expensive. “

Clément Beaune, however, refrained from specifying the amount of these increases, as did the European Commission, which remains silent on contracts with laboratories highlighting a “contractual requirement”. “Everything concerning information such as the price of vaccines is covered by confidentiality, it is a very important obligation,” Stefan De Keersmaecker, a Commission spokesperson, said during a press briefing at Brussels on December 18th. The European Commission has not commented on the news from the British daily.

According to Financial Times, which explains having obtained the contract concluded between the two American companies and the EU, the Pfizer vaccine should go from 15.5 euros to 19.5 euros and that of Moderna from 19 euros to 21.5 euros. These increases take place in the midst of the outbreak of the Delta variant which is not without raising concerns among some as to the supposed efficacy of vaccines against this variant.

For its part, Pfizer planned at the end of July to sell this year for 28.23 billion euros of vaccines against Covid-19, much more than the 21.91 billion euros forecast two months earlier. In May, Moderna counted on the annual sale of 16.43 billion euros of vaccines to fight against Covid-19.



Source link